Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Demant Share Issue/Capital Change 2026

Apr 8, 2026

3360_rns_2026-04-08_f291992d-dd62-425a-b6dc-0bcc5def65bc.pdf

Share Issue/Capital Change

Open in viewer

Opens in your device viewer

Demant

Demant A/S: Completion of capital reduction

8.4.2026 11:02:53 CEST | Demant A/S | Total number of voting rights and capital

Company announcement no 2026-07 8 April 2026

Completion of capital reduction in Demant A/S

As stated in company announcement no. 2026-05, it was decided at Demant A/S' ordinary general meeting on 5 March 2026 to reduce the company's share capital by nominally DKK 408,274.40 divided into 2,041,372 shares of DKK 0.20, corresponding to the company's holding of treasury shares as at 3 February 2026 less shares to cover share-based retention programmes for senior leadership and the Executive Board.

The capital reduction was published via the electronic information system of the Danish Business Authority on 6 March 2026. The advertisement period expired without any objections being raised. Consequently, we have notified the Danish Business Authority of the capital reduction. After the capital reduction, the share capital of Demant A/S amounts to nominally DKK 42,350,658.20.

In accordance with section 32 of the Danish Capital Markets Act, we hereby state that the company's total share capital and total number of voting rights amount to:

Share capital (nominal): DKK 42,350,658.20

Number of voting rights: 211,753,291

Further information:
Peter Pudselykke, Head of Investor Relations
Gustav Høegh, Investor Relations Officer
Maribel Alonso Francisco, Communication Manager
Phone +45 3917 7300
www.demant.com

Contacts

About Demant A/S

Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices, hearing implants, diagnostics to audio and video solutions and hearing care all over the world, Demant is active and engaged. Our innovative technologies and know-how help improve people's health and hearing. We create life-changing differences through hearing health.

Attachments

  • 2026-07 Completion of capital reduction.pdf